Insider trade

Acadia Pharmaceuticals (ACAD): CFO sold ~$69K

Mark C. Schneyer, CFO at Acadia Pharmaceuticals, sold ~$69K of Acadia Pharmaceuticals shares.

~$69K
Approx. value · 3,321 sh @ $20.88: 71K
Holds after · shares reported

Traded: Oct 30, 2026
Filed: Oct 31, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“As of October 23, 2026, Dr. Thompson will no longer serve as an employee of the Company or function in her former role as Head of Research and Development. Also, effective October 23, 2026, Dr Thompson will be retained as a consultant by the Company and intends to provide limited consulting services to the Company through December 31, 2026.”
Oct 30, 2026 · this disclosureInsiderCFO sold ~$69K of ACAD shares in the open market

What came next

Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 4.4%

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Acadia Pharmaceuticals

For Acadia Pharmaceuticals, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACAD page.

Other recent filings by Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER

The full history of Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER is on the profile page.

How this filing works

Explore the data

Other disclosures at Acadia Pharmaceuticals

Everything OQRO holds on this company is on its ACAD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data